Brief: Orchard Therapeutics Presents Two-Year Follow-Up Data Versus Historical Control From Registrational Trial Of Otl-101
22/02/2019 14:01
Feb 22 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS PRESENTS TWO-YEAR FOLLOW-UP DATA
VERSUS
HISTORICAL CONTROL FROM REGISTRATIONAL TRIAL OF OTL-101 FOR THE
TREATMENT OF ADA-SCID
Source text for Eikon: ID:nGNX1fXhQ0
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln